Abstract
Introduction: The main metabolic alteration of chronic kidney disease-mineral and bone disorder (CKD-MBD) is secondary hyperparathyroidism (SHPT), resulting in bone mass loss. One of the factors characterizing SHPT is the increase in circulating parathyroid hormone (PTH). Elevated total PTH concentration is correlated with left ventricular hypertrophy (LVH). However, it is not known which…